FII selling Vs Q2 earnings – What’s the big worry for the markets now? A look at key Nifty levels to watch

The markets have been struggling for the past 6 sessions and the investors have turned significantly cautious. Both the Sensex and Nifty are off 10% from their recent highs. Though the sectoral indices saw some bounceback on November 14, the Sensex is nearly 8000 points down from its all-time highs while the The Nifty settled around a key support level of 23,500 in trade today.

Over Rs 23 lakh crore worth of investor wealth has been wiped off in the past few sessions. One of the reasons for this sharp cut has been the huge outflow in the past few weeks. For November so far, FIIs have already sold over Rs 27,000 crore.

Also ReadBloodbath on D’Street; Nifty off 10% from recent highs, Sensex slides 1000 points – Is there room for further correction?

FII selling not a big worry

The question that’s worrying most investors now is how much more would the FIIs sell and how this would impact markets. Dhiraj Relli, Managing director of HDFC Securities, is not worried. He pointed out that domestic investors have the wherewithal to absorb this selling spree by the FIIs, “We have seen unprecedented outflows from FPIs in October and in the last 25 odd years similar kind of 10 billion outflows were seen only twice. Once in 2009 and in 2020 during Covid-19. If you look at now, the market has been very resilient. FPIs definitely will find US more attractive after Trump’s victory so they may not invest as much in EMs. We may continue to see outflows for some more time. But it is adequately compensated by Indian investment community. That’s where we see good inflows from SIPs. So domestic institutions are able to absorb this FPI selling with ease.”

Is earnings the big worry?

Earnings appear to be the bigger cause for concern as most companies reported muted results in Q2.

According to Deven Choksey, managing director of DRChoksey FinServ, “One of the reason for the fall is de-rating of the stocks after the second quarter earnings announcement but the earnings performance is unlikely to cause any permanent damage. In my viewpoint, the second half of the financial year would be significantly better compared to the first half of the financial year, and that’s where probably, I think you are likely to see the earnings recovering back,” and this he believes will give opportunity to investors to buy stocks at lower levels.

 » Read More

Related Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of